DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

Published on Oct 6, 2016in BMC Cancer3.15
· DOI :10.1186/S12885-016-2813-0
Imran Petkar6
Estimated H-index: 6
(The Royal Marsden NHS Foundation Trust),
Keith Rooney6
Estimated H-index: 6
(Belfast Health and Social Care Trust)
+ 14 AuthorsChristopher M. Nutting69
Estimated H-index: 69
(The Royal Marsden NHS Foundation Trust)
Sources
Abstract
Background Persistent dysphagia following primary chemoradiation (CRT) for head and neck cancers can have a devastating impact on patients’ quality of life. Single arm studies have shown that the dosimetric sparing of critical swallowing structures such as the pharyngeal constrictor muscle and supraglottic larynx can translate to better functional outcomes. However, there are no current randomised studies to confirm the benefits of such swallow sparing strategies. The aim of Dysphagia/Aspiration at risk structures (DARS) trial is to determine whether reducing the dose to the pharyngeal constrictors with dysphagia-optimised intensity- modulated radiotherapy (Do-IMRT) will lead to an improvement in long- term swallowing function without having any detrimental impact on disease-specific survival outcomes.
📖 Papers frequently viewed together
1,091 Citations
268 Citations
507 Citations
References51
Newest
#1Katherine A. Hutcheson (University of Texas MD Anderson Cancer Center)H-Index: 33
#2Martha P. Barrow (University of Texas MD Anderson Cancer Center)H-Index: 11
Last. Jan S. Lewin (University of Texas MD Anderson Cancer Center)H-Index: 52
view all 16 authors...
BACKGROUND: The National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE) is the universal framework for toxicity reporting in oncology trials. The objective of this study was to develop a CTCAE-compatible modified barium swallow (MBS) grade for the purpose of grading pharyngeal dysphagia as a toxicity endpoint in cooperative-group organ-preservation trials for head and neck cancer (HNC). It was hypothesized that a 5-point, CTCAE-compatible MBS grade (Dynamic Imaging Gra...
81 CitationsSource
#1Katherine A. Hutcheson (University of Texas MD Anderson Cancer Center)H-Index: 33
#2Martha P. Barrow (University of Texas MD Anderson Cancer Center)H-Index: 11
Last. Jan S. LewinH-Index: 52
view all 6 authors...
Objective/Hypothesis To describe clinically relevant between-group differences in MD Anderson Dysphagia Inventory (MDADI) scores among head and neck cancer (HNC) patients. Study Design Retrospective cross-sectional study was conducted in 1,136 HNC patients seen for modified barium swallow (MBS) studies. Methods The MDADI was administered by written questionnaire at the MBS appointment. MD Anderson Dysphagia Inventory global, composite, and subscale scores were calculated. Anchor-based methods we...
63 CitationsSource
#1J. TylerH-Index: 1
#2D. BernsteinH-Index: 1
Last. Christopher M. NuttingH-Index: 69
view all 4 authors...
1 CitationsSource
#1Miranda E.M.C. Christianen (UMCG: University Medical Center Groningen)H-Index: 16
#2Arjen van der Schaaf (UMCG: University Medical Center Groningen)H-Index: 20
Last. Johannes A. Langendijk (UMCG: University Medical Center Groningen)H-Index: 86
view all 14 authors...
Purpose: The aim of this study was to clinically validate a multivariable normal tissue complication probability (NTCP) model for grade 2-4 swallowing dysfunction at 6 months after radiotherapy or chemoradiation (SWAL(M6)) in head and neck cancer patients treated with swallowing sparing intensity modulated radiotherapy (SW-IMRT) and to test if SW-IMRT resulted in a reduction of the prevalence of SWAL(M6). Materials and methods: The primary endpoint was SWAL(M6). For all 186 patients, a standard ...
42 CitationsSource
#1Francesca De Felice (Guy's and St Thomas' NHS Foundation Trust)H-Index: 21
#2C. Thomas (Guy's and St Thomas' NHS Foundation Trust)H-Index: 5
Last. Teresa Guerrero Urbano (Guy's and St Thomas' NHS Foundation Trust)H-Index: 11
view all 6 authors...
Summary Objectives To investigate the anatomical distribution of loco-regional treatment failures (LRF) in patients with head and neck squamous cell carcinoma (HNSCC) in relation to clinical target volume (CTV) delineation. Materials and methods 56 patients with LRF were retrospectively identified. Patients were previously treated with radical intensity modulated radiotherapy (IMRT) +/− chemotherapy. Target volumes include gross tumour volume (GTV), its volumetric expansion of 10 mm (GTV-HD), CT...
36 CitationsSource
#1Teresa Brown (UQ: University of Queensland)H-Index: 13
#2Merrilyn Banks (Royal Brisbane and Women's Hospital)H-Index: 24
Last. Judith Bauer (UQ: University of Queensland)H-Index: 49
view all 6 authors...
New radiotherapy techniques do not reduce the need for nutrition intervention in patients with head and neck cancer
14 CitationsSource
#1Miranda E.M.C. Christianen (UMCG: University Medical Center Groningen)H-Index: 16
#2Irma M. Verdonck-de Leeuw (VUmc: VU University Medical Center)H-Index: 46
Last. Johannes A. Langendijk (UMCG: University Medical Center Groningen)H-Index: 86
view all 13 authors...
Abstract Objectives To identify patterns of long-term, radiation-induced swallowing dysfunction after definitive radiotherapy with or without chemotherapy (RT or CHRT) and to determine which factors may explain these patterns over time. Material and methods The study population consisted of 238 consecutive head and neck cancer patients treated with RT or CHRT. The primary endpoint was ⩾grade 2 swallowing dysfunction at 6, 12, 18 and 24months after treatment. Cluster analysis was used to identify...
51 CitationsSource
Human papillomavirus–associated oropharynx cancer (HPVA-OPC) is rapidly increasing in incidence and has unique epidemiologic, molecular, and biologic characteristics. Despite being recognized as having superior prognosis, current evidence does not support less intense therapy compared with HPV-negative OPC. Current combined modality therapies confer a significant risk of morbidity, and patients with HPVA-OPC have a younger median age. These patients, therefore, live longer with the adverse effec...
95 CitationsSource
#1Waheeda Owadally (Velindre NHS Trust)H-Index: 1
#2Chris Nicholas Hurt (Cardiff University)H-Index: 26
Last. Mererid Evans (Velindre NHS Trust)H-Index: 17
view all 13 authors...
Human papillomavirus-positive oropharyngeal squamous cell carcinoma is increasing in incidence worldwide. Current treatments are associated with high survival rates but often result in significant long-term toxicities. In particular, long-term dysphagia has a negative impact on patient quality of life and health. The aim of PATHOS is to determine whether reducing the intensity of adjuvant treatment after minimally invasive transoral surgery in this favourable prognosis disease will result in bet...
117 CitationsSource
#1Caroline E. McCarthy (University of Liverpool)H-Index: 3
#2John K. Field (University of Liverpool)H-Index: 86
Last. Michael W. Marcus (University of Liverpool)H-Index: 15
view all 5 authors...
Recent studies show an increased incidence of head and neck cancers worldwide. The present study evaluated the trend in the incidence of head and neck cancers in England during 2002-2011. Data were extracted from the database of Office for National Statistics. The study population was cate - gorised according to age, residential area, gender and cancer sub-types. Overall trend in incidence of head and neck cancer and some subtypes were examined using Poisson regression models. In total, 71,457 h...
21 CitationsSource
Cited By49
Newest
#1Roi Dagan (UF: University of Florida)H-Index: 15
#2Thomas J. Galloway (Fox Chase Cancer Center)H-Index: 22
Human papillomavirus-associated oropharyngeal cancer (HPV-OPC) is a distinct clinical entity with a favorable prognosis compared with non-HPV-OPC. Surgery and radiotherapy (RT) result in adverse effects, and negative quality of life or functional outcomes, which impact a significant proportion of HPV-OPC survivors. Ongoing studies aim to reduce these negative treatment effects while maintaining high cure rates through deintensified therapy typically use either a primary surgical or RT approach. ...
Source
#1M. Vreugdenhil (Queen Elizabeth Hospital Birmingham)H-Index: 1
#2Charles Fong (Queen Elizabeth Hospital Birmingham)H-Index: 2
Last. Christopher M. Nutting (The Royal Marsden NHS Foundation Trust)H-Index: 69
view all 18 authors...
AIMS The De-ESCALaTE study showed an overall survival advantage for the administration of synchronous cisplatin chemotherapy with radiotherapy in low-risk oropharyngeal cancer when compared with synchronous cetuximab. During the trial, a radiotherapy quality assurance protocol amendment permitted centres to swap from the original radiotherapy contouring protocol (incorporating the whole oropharynx into the high-dose clinical target volume (CTV); anatomical protocol) to a protocol that incorporat...
Source
#1Mona Arbab (IU: Indiana University)H-Index: 5
#2G. Bartlett (IU: Indiana University)H-Index: 3
Last. Mark Langer (IU: Indiana University)H-Index: 14
view all 5 authors...
An isotropic expanded Planning Target Volume (PTV) neglects patient’s off-axis rotation. This study designs a rotational PTV that is used instead of the standard 3-mm Clinical Target Volume (CTV) expanded PTV in oropharyngeal cancers with the goal to reduce pharyngeal constrictor muscle (PCM) mean dose. 10 patients were retrospectively evaluated. For off-axis rotation, the image was rotated around the longitudinal axis (cervical spinal canal) ± 5 degrees. These new CTVs were combined to form the...
1 CitationsSource
#1Christopher M. Nutting (The Royal Marsden NHS Foundation Trust)H-Index: 69
#2Clare Griffin (ICR: Institute of Cancer Research)H-Index: 15
Last. Amen Sibtain (St Bartholomew's Hospital)
view all 30 authors...
BACKGROUND Radical (chemo)radiotherapy offers potentially curative treatment for patients with locally advanced laryngeal or hypopharyngeal cancer. We aimed to show that dose-escalated intensity-modulated radiotherapy (DE-IMRT) improved locoregional control. METHODS We performed a phase III open-label randomised controlled trial in patients with laryngeal or hypopharyngeal cancer (AJCC III-IVa/b, TNM 7). Patients were randomised (1:1) to DE-IMRT or standard dose IMRT (ST-IMRT) using a minimisati...
Source
#1Michelle Mierzwa (UM: University of Michigan)H-Index: 15
#2Laila A. Gharzai (UM: University of Michigan)H-Index: 5
Last. Yue Cao (UM: University of Michigan)H-Index: 43
view all 17 authors...
ABSTRACT Purpose Prediction of individual patient sensitivity to radiotherapy (RT), for tumor control or normal tissue toxicity is necessary to individualize treatment planning. In head and neck cancer, radiation doses are limited by many nearby critical structures including structures involved in swallowing. Previous efforts showed that imaging parameters correlate with RT dose; here, we investigate the role of DCE-MRI blood volume (BV) changes in predicting dysphagia. Methods and Materials Thi...
1 CitationsSource
#1Alana R. Hutchison (UQ: University of Queensland)H-Index: 1
#2Laurelie R. Wishart (UQ: University of Queensland)H-Index: 1
Last. Sandro Porceddu (QUT: Queensland University of Technology)
view all 7 authors...
This study explored associative relationships between radiotherapy dose volumes delivered to the dysphagia aspiration risk structures (DARS) and swallowing physiological disturbance at 3 months post treatment in a homogenous cohort of patients who received (chemo)radiotherapy ((C)RT) for oropharyngeal head and neck cancer (HNC). Participants(n = 53) were a subgroup of patients previously recruited as part of a prospective randomised trial, and had undergone physiological swallowing assessment us...
Source
#1Alexander RühleH-Index: 9
#2Anca-Ligia GrosuH-Index: 31
Last. Nils H. NicolayH-Index: 19
view all 3 authors...
Oncological outcomes for head-and-neck squamous cell carcinoma (HNSCC) patients are still unsatisfactory, especially for advanced tumor stages. Besides the moderate survival rates, the prevalence of severe treatment-induced normal tissue toxicities is high after multimodal cancer treatments, both causing significant morbidity and decreasing quality of life of surviving patients. Therefore, risk-adapted and individualized treatment approaches are urgently needed for HNSCC patients to optimize the...
3 CitationsSource
#1Daniel J. Lin (Newcastle University)H-Index: 1
#2Jenan Altamimi (Newcastle University)
Last. Joanne Patterson (RMIT: RMIT University)H-Index: 19
view all 5 authors...
The MD Anderson Dysphagia Inventory (MDADI) is a 20-item dysphagia-specific QOL questionnaire with four subscales: global, emotional, functional, and physical. It is widely used in clinical practice and in research; however, its psychometric properties have been under-researched. We aim to evaluate the organisation of the MDADI subscales and identify any redundant items. The MDADI is a routinely collected outcome measure at two centres in northeast England. Questionnaires completed at three mont...
Source
#1Imran PetkarH-Index: 6
#2D. McQuaid (The Royal Marsden NHS Foundation Trust)H-Index: 12
Last. Christopher M. NuttingH-Index: 69
view all 6 authors...
Abstract: Background and purpose To evaluate the inter-observer variation (IOV) in pharyngeal constrictor muscle (PCM) contouring, and resultant impact on dosimetry and estimated toxicity, as part of the pre-trial radiotherapy trial quality assurance (RTQA) within DARS, a multicentre phase III randomised controlled trial investigating the functional benefits of dysphagia-optimised intensity-modulated radiotherapy (Do-IMRT) in pharyngeal cancers. Methods and materials Outlining accuracy of 15 cli...
Source
#1M. Vreugdenhil (University of Birmingham)H-Index: 1
#2Charles Fong (Queen Elizabeth Hospital Birmingham)H-Index: 2
Last. Hisham Mehanna (University of Birmingham)H-Index: 44
view all 6 authors...
There has been increased interest in hypofractionated accelerated chemoradiation for head and neck cancer during the recent first peak of the COVID-19 pandemic. Prospective data regarding this approach from randomised trials is lacking. In the PET NECK study, 564 patients with squamous cell carcinoma of the head and neck receiving definitive chemoradiation were randomised to either planned neck dissection or PET CT scan guided surveillance. In this surgical trial, three radiotherapy fractionatio...
6 CitationsSource